Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial.
Candice DelcourtXia WangZien ZhouJoanna Marguerite WardlawGrant MairThompson G RobinsonXiaoying ChenSohei YoshimuraTakako Torii-YoshimuraCheryl CarcelZeljka CalicWee Yong TanAlejandra MalaveraCraig S AndersonRichard I LindleyPublished in: Journal of neurology, neurosurgery, and psychiatry (2020)
Non-expert-defined brain imaging signs of brain frailty and acute ischaemia contribute to the prognosis of thrombolysis-treated AIS patients for sICH and mortality. However, these imaging features showed no interaction with alteplase dose.
Keyphrases
- high resolution
- resting state
- white matter
- newly diagnosed
- ejection fraction
- functional connectivity
- clinical trial
- cerebral ischemia
- randomized controlled trial
- study protocol
- intensive care unit
- multiple sclerosis
- brain injury
- drug induced
- respiratory failure
- mass spectrometry
- hepatitis b virus
- phase iii
- photodynamic therapy
- subarachnoid hemorrhage
- aortic dissection